Abbott Laboratories (ABT) Shares Repurchased (2009 - 2026)

Abbott Laboratories' Shares Repurchased history runs 18 years deep, the most recent figure standing at $180.0 million for Q1 2026.

• In Q1 2026, Shares Repurchased fell 35.71% year-over-year to $180.0 million; the TTM figure through Mar 2026 stood at $793.0 million (down 41.22% YoY), while the FY2025 annual figure was $893.0 million, down 31.04% from the prior year.
• Shares Repurchased came in at $180.0 million for Q1 2026 at Abbott Laboratories, down from $302.0 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $2.3 billion in Q1 2022 to a low of $2.0 million in Q3 2023.
• A 5-year average of $434.7 million and a median of $302.0 million in 2025 frame the typical range for Shares Repurchased.
• Across the five-year window, Shares Repurchased slumped 99.75% in 2023 and soared 37450.0% in 2024, its largest moves.
• Abbott Laboratories' Shares Repurchased stood at $685.0 million in 2022, then tumbled by 62.19% to $259.0 million in 2023, then rose by 21.62% to $315.0 million in 2024, then declined by 4.13% to $302.0 million in 2025, then plunged by 40.4% to $180.0 million in 2026.
• According to Business Quant data, Shares Repurchased over the past three periods registered $180.0 million, $302.0 million, and $305.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison